CLINICAL SIGNIFICANCE OF CASPASE-3 EXPRESSION IN PATHOLOGIC-STAGE I, NONSMALL-CELL LUNG CANCER

被引:0
|
作者
Jiang, Dong [1 ]
Zheng, Shiying [1 ]
Li, Hong [2 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Suzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Dept Geriatr, Suzhou, Peoples R China
关键词
caspase-3; Prognosis; Lung cancer; apoptosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S1247 / S1248
页数:2
相关论文
共 50 条
  • [21] Caspase-3 expression in human gastric carcinoma and its clinical significance
    Isobe, N
    Onodera, H
    Mori, A
    Shimada, Y
    Yang, W
    Yasuda, S
    Fujimoto, A
    Ooe, H
    Arii, S
    Kitaichi, M
    Imamura, M
    ONCOLOGY, 2004, 66 (03) : 201 - 209
  • [22] Regular follow-up for patients irradiated for early stage nonsmall-cell lung cancer too!
    Jeremic, B
    Classen, J
    Bamberg, M
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (04) : 1065 - 1066
  • [23] Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC)
    Hof, Holger
    Muenter, Marc
    Oetzel, Dieter
    Hoess, Angelika
    Debus, Juergen
    Herfarth, Klaus
    CANCER, 2007, 110 (01) : 148 - 155
  • [24] Clinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer
    Kim, Gun-Jik
    Lee, Jae-Ho
    Lee, Deok Heon
    MEDICINE, 2017, 96 (03)
  • [25] Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer
    Bryant, Alex K.
    Yin, Huiying
    Schipper, Matthew J.
    Paximadis, Peter A.
    Boike, Thomas P.
    Bergsma, Derek P.
    Movsas, Benjamin
    Dess, Robert T.
    Mietzel, Melissa A.
    Kendrick, Randi
    Seferi, Merita
    Dominello, Michael M.
    Matuszak, Martha M.
    Jagsi, Reshma
    Hayman, James A.
    Pierce, Lori J.
    Jolly, Shruti
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (04): : 142 - 145
  • [26] The prognostic significance of Caspase-3 and survivin expression in colorectal cancer patients
    Touloumis, Zisis
    Lazaris, Andreas
    Griniatsos, John
    JOURNAL OF BUON, 2020, 25 (05): : 2160 - 2170
  • [27] Stage I and II nonsmall cell lung cancer treatment options
    Hardavella, Georgia
    Magouliotis, Dimitrios E.
    Chalela, Roberto
    Januszewski, Adam
    Dennstaedt, Fabio
    Putora, Paul Martin
    So, Alfred
    Bhowmik, Angshu
    BREATHE, 2024, 20 (02)
  • [28] Is major pathologic response sufficient to predict survival in resectable nonsmall-cell lung cancer patients receiving neoadjuvant chemotherapy?
    Cai, Jing-Sheng
    Li, Shuo
    Yan, Shu-Mei
    Yang, Jie
    Yang, Mu-Zi
    Xie, Chu-Long
    Li, Ji-Bin
    Feng, Yan-Fen
    Yang, Hao-Xian
    Hou, Xue
    THORACIC CANCER, 2021, 12 (09) : 1336 - 1346
  • [29] CDNA microarray analysis of gene expression in pathologic stage IA nonsmall cell lung carcinomas
    Nakamura, H
    Saji, H
    Ogata, A
    Hosaka, M
    Hagiwara, M
    Saijo, T
    Kawasaki, N
    Kato, H
    CANCER, 2003, 97 (11) : 2798 - 2805
  • [30] The Significance of One-Station N2 Disease in the Prognosis of Patients With Nonsmall-Cell Lung Cancer
    Misthos, Panagiotis
    Sepsas, Evangelos
    Kokotsakis, John
    Skottis, Ion
    Lioulias, Achilleas
    ANNALS OF THORACIC SURGERY, 2008, 86 (05): : 1626 - 1631